EMA Authorised: Veoza (fezolinetant) — Astellas Pharma Europe B.V.

View source ↗

Summary

The European Medicines Agency authorised Veoza (fezolinetant) from Astellas Pharma Europe B.V. for the treatment of menopausal vasomotor symptoms, including hot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Veoza (fezolinetant)

Snippet

Status: Authorised. Therapeutic area: Menopause;Hot Flashes. MAH: Astellas Pharma Europe B.V.. Decision date: 21/04/2026